Results from a clinical trial of CUE1+, a chest-mounted device, has shown it’s well tolerated by people with Parkinson’s and has the potential to help manage movement symptoms.
Parkinson’s UK share our latest clinical publication
More From the Press
Parkinson’s Insights share our latest clinical publication and transitional journey towards Class IIa medical device certification
Charco Neurotech prepares to relaunch CUE1+ following trial findings and medical device certification. Read article
Read moreCharco Neurotech announces publication of a pilot RCT, with data highlighting that the CUE1+ is safe, well tolerated, with encouraging signals for motor symptom relief in people with Parkinson’s
A double-blind, placebo-controlled study of 50 people with Parkinson’s, published in Parkinson’s Disease, part of the Nature Portfolio, is the first…
Read moreCharco Neurotech Achieves ISO 13485:2016 Certification
We are proud to announce that we have achieved ISO 13485 certification, the internationally recognised quality management system…
Read more